Clinical Trials Browser

Phase 1 × Not yet recruiting × Leukemia, Plasma Cell × Clear all

NCT06655519 2024-10-23

An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Phase 1 Not yet recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma